BACKGROUND Complications like sepsis due to infection and death can occur in the treatment of major burn trauma patients because of inflammation process. The Neutrophil-to-Lymphocyte Ratio (NLR) is believed as a prognostic marker for the incidence of mortality and sepsis in burns patient care. Various studies have stated that NLR is quite easy, inexpensive and efficient tool for clinical application. AIMS to analyze the role of NLR as prognostic marker for mortality and sepsis in burn patients. METHODS A cross-sectional retrospective single-center study was conducted between 2019 -2021 using 222 medical records from 245 burn patients at our Burns Unit. Demographics and laboratory data results were recorded, including NLR levels on 1 st and 3 rd day of treatment. Correlation analysis of NLR levels was carried out on the incidence of mortality and sepsis using Logistic Regression and Chi Square tests. RESULTSThe subjects of this study were dominated by patients with median age of 33 years old (SD ±20), male (68.5%) and average burns area of 30.22% (SD ±23.3%). This study noted that the NLR on 1 st day (cutoff of 7.97) and 3 rd day (cutoff of 6.2) of treatment had a correlation with the incidence of mortality and sepsis (p<0.05). CONCLUSION Neutrophil-to-Lymphocyte Ratio (NLR) can be used as a prognostic marker of mortality and sepsis in burn patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.